食品伙伴网讯 2019年6月18日，据欧盟食品安全局（EFSA）消息，应欧盟委员会要求，欧盟动物饲料添加剂和产品（FEEDAP）研究小组就修改BioPlus 2B（地衣芽孢杆菌DSM 5749和枯草芽孢杆菌DSM 5750）作为火鸡育肥饲料的授权条件发表科学意见。

　　据了解，拟议的授权条件不会修改先前关于添加剂安全性的结论。但这种添加剂应被视为一种潜在的呼吸道致敏物质，专家组无法断定该添加剂对皮肤和眼睛的刺激性或其皮肤致敏性。

　　部分原文报道如下：

　　Following a request from the European Commission, the Panel on Additives and Products or Substances used in Animal Feed （FEEDAP） was asked to deliver a scientific opinion on the modification of the terms of the authorisation of BioPlus? 2B （Bacillus licheniformis DSM 5749 and Bacillus subtilis DSM 5750） in feeds for turkeys for fattening to allow the simultaneous use with a battery of permitted coccidiostats （diclazuril, halofuginone, monensin sodium, robenidine hydrochloride, maduramicin ammonium, lasalocid sodium） and with the preservative formic acid. Conclusions previously drawn by the FEEDAP Panel on the compatibility of the additive for chickens for fattening apply to the current application provided that the maximum authorised concentration of the coccidiostats semduramycin, maduramicin ammonium, lasalocid sodium and the preservative formic acid for turkeys for fattening （when maximum authorised concentrations exist）， are equal or lower than those for chickens for fattening. Considering the data submitted, the FEEDAP Panel concludes that BioPlus? 2B （B. licheniformis DSM 5749 and B. subtilis DSM 5750） is compatible with diclazuril and monensin sodium. based on the data provided, no conclusion can be drawn for robenidine hydrochloride. In the absence of data, no conclusion can be drawn for halofuginone.